The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT04789616

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04789616
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04789616. Randomized; quadruple masking; primary purpose treatment. Start 2022-09-15 (actual); primary completion 2025-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke
Acronym
CAMAROS
Condition
Stroke
Intervention (Drug)
Maraviroc
Intervention (Behavioral)
Exercise Program
Intervention (Other)
Placebo
Intervention (Device)
Activity Sensor
Intervention (Behavioral)
Motor Learning
Lead sponsor
University of Calgary (class: other)
Collaborator
University Health Network, Toronto (class: other)
Collaborator
University of California, Los Angeles (class: other)
Collaborator
Sunnybrook Health Sciences Centre (class: other)
Collaborator
University of British Columbia (class: other)
Collaborator
Memorial University of Newfoundland (class: other)
Collaborator
Dalhousie University (class: other)
Collaborator
Parkwood Hospital, London, Ontario (class: other)
Collaborator
Riverview Health Centre Foundation (class: other)
Collaborator
The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (class: not stated)

Record details

Record id
cardio:ct-nct04789616
Content hash
25a1e2bb1a1c215ca4ff15cb4db263df72e539fcb012ab5b57f1c3b28b533f1f